Arch Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Arch Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2023.
  • Arch Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$4.63M, a 473% decline year-over-year.
  • Arch Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$1.94M, a 548% decline from 2022.
  • Arch Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $433K, a 217% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1.94M -$2.37M -548% Oct 1, 2022 Sep 30, 2023 10-K 2024-02-15
2022 $433K +$296K +217% Oct 1, 2021 Sep 30, 2022 10-K 2024-02-15
2021 $137K Oct 1, 2020 Sep 30, 2021 10-K 2022-12-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.